3 | SEC Filings Hub

Filing metadata

Accession number: 0001233539-26-000003
Form type: Form 3
Filer: Quince Therapeutics, Inc.
CIK: CIK 1662774
Filed: Oct 19, 2026
Reporting period: Oct 08, 2026
Description: Initial ownership

Documents

0001233539-26-000003-index.htm

Complete submission

0001233539-26-000003.txt

directory listing

Filed by

Quince Therapeutics, Inc.